Geneos Wealth Management’s MarineMax HZO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-700
Closed -$41K – 2859
2021
Q4
$41K Hold
700
– – ﹤0.01% 1558
2021
Q3
$35K Sell
700
-200
-22% -$9.98K ﹤0.01% 1658
2021
Q2
$43K Sell
900
-250
-22% -$13K ﹤0.01% 1553
2021
Q1
$65K Hold
1,150
– – ﹤0.01% 1497
2020
Q4
$56K Buy
1,150
+250
+28% +$7.83K ﹤0.01% 1400
2020
Q3
$22K Buy
+900
New +$24.7K ﹤0.01% 1611

Other funds holding HZO

Geneos Wealth Management's HZO Position: Q1 2022 in Review

Geneos Wealth Management sold out of MarineMax (HZO) in Q1 2022, closing a stake of 700 shares — an estimated $41K sold.

Geneos Wealth Management first reported a position in HZO in Q3 2020 and held it in 6 quarters. The position peaked at $65K in Q1 2021. 227 funds tracked by Wall St. Rank hold HZO as of Q1 2022.

  • Geneos Wealth Management reported no remaining MarineMax position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 700 MarineMax shares in Q1 2022, an estimated $41K.
  • Geneos Wealth Management first reported a position in MarineMax in Q3 2020 and held it in 6 quarters.
  • Geneos Wealth Management's MarineMax position peaked at $65K in Q1 2021.
  • 227 funds tracked by Wall St. Rank held MarineMax as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.